ArticleGastroenterology and hepatology from bed to bench2025
Betaine attenuates fatty changes via antioxidant responses against oxytetracycline-induced fatty liver in rats.
Article in Gastroenterology and hepatology from bed to bench, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This study aimed to investigate the antioxidant properties of betaine against oxytetracycline-induced fatty liver disease. Background: During the past decades, fatty liver has been considered a public health concern, with prevalence between 10-24% in the world. Betaine has been shown to have some antioxidant properties in our previous studies. Methods: For this purpose, 32 male Wistar rats, were divided into four groups: control, betaine (Bet., betaine 10 mg/kg daily for 15 days, orally), fatty liver (Fat., induction of fatty liver with oxytetracycline 120 mg/kg during three consecutive days, ip), and fatty liver + betaine group (Fat. + Bet.). On the 19th day, after complete anesthesia, blood samples were taken from the heart, and the liver was sampled for biochemical and histopathology evaluations. Results: Betaine significantly increased glutathione peroxidase activity (Gpx) in the Bet. and Fat. + Bet. Groups compared to the Fat group (P <0.05). In this regard, glutathione (GSH) content and the total antioxidant capacity (TAC) increased significantly in the betaine-treated rats and Fat. + Bet. group compared to the Fat. Group (P <0.05). Regarding lipid peroxidation, malondialdehyde concentration significantly decreased in Bet. and Fat. + Bet. Groups, when compared to fat. Group (P <0.05). Betaine was able to reduce tissue necrosis and decrease the number of Kupffer cells, restoring the standard color of the cytoplasm of hepatocytes. Conclusion: The antioxidant properties of betaine are able to prevent fatty liver and oxidative stress in the oxytetracycline-induced fatty liver of rats. The antioxidant properties of betaine appear to prevent fatty liver and oxidative stress in rats with oxytetracycline-induced fatty liver.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.